Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAvacta Group Regulatory News (AVCT)

Share Price Information for Avacta Group (AVCT)

Share Price is delayed by 15 minutes
Get Live Data
71.50    1.50 (2.14%)
Bid:
71.00
Ask:
72.00
Spread: 1.00 (1.408%)
Market Cap: £325.40m
AVCT Live PriceLast checked at - London Stock Exchange

Intraday Avacta Group Share Chart

Director/PDMR Shareholding

8 Jan 2009 14:29

RNS Number : 3467L
Avacta Group PLC
08 January 2009
 

Avacta Group plc

("Avacta" or "the Company")

Director/PDMR Shareholding

Pursuant to the announcements made on 22 July 2008 and 20 November 2008 in relation to the holding of ordinary shares of 0.1p each ("Ordinary Shares") by Alastair Smith, Chief Executive Officer, the Board of the Company would now wish to clarify his resultant beneficial holding.

Following the sales of 601,389 Ordinary Shares and 3,061,464 Ordinary Shares to Alastair's Self Invested Pension Plan ("SIPP"), his correct resultant beneficial holding is 49,577,022 Ordinary Shares, representing approximately 6.02 per cent. of the current issued share capital of the Company. A total of 40,446 Ordinary Shares were sold at the time of the transactions in order to satisfy settlement and commission charges.

For further information, please contact:

Avacta Group plc 

Alastair Smith, Chief Executive Officer

Tim Sykes, Chief Financial Officer

www.avacta.com

Tel: 0870 835 4367

Daniel Stewart & Company plc 

Lindsay Mair/Tessa Smith

www.danielstewart.co.uk

Tel: 020 7776 6550

Novum Securities Limited

Henry Turcan/Michael Brennan

Tel: 020 7562 4700

Haggie Financial LLP 

Nicholas Nelson/Kathy Boate

Nicholas.nelson@haggie.co.uk

Tel: 020 7417 8989

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSCKFKBQBKDFDK
Date   Source Headline
21st Dec 20207:00 amRNSLicense Agreement with Astrea Bioseparations
23rd Nov 20209:05 amRNSSecond Price Monitoring Extn
23rd Nov 20209:00 amRNSPrice Monitoring Extension
23rd Nov 20207:00 amRNSSARS-CoV-2 Rapid Antigen Test Update
18th Nov 20204:40 pmRNSSecond Price Monitoring Extn
18th Nov 20204:36 pmRNSPrice Monitoring Extension
13th Nov 20202:15 pmRNSIssue of Equity
10th Nov 202011:06 amRNSSecond Price Monitoring Extn
10th Nov 202011:00 amRNSPrice Monitoring Extension
9th Nov 20202:06 pmRNSSecond Price Monitoring Extn
9th Nov 20202:01 pmRNSPrice Monitoring Extension
22nd Oct 20201:50 pmRNSDirector/PDMR Shareholding
8th Oct 20209:00 amRNSIssue of Equity
30th Sep 20202:05 pmRNSSecond Price Monitoring Extn
30th Sep 20202:00 pmRNSPrice Monitoring Extension
30th Sep 202010:35 amRNSLaunch of SARS-CoV-2 BAMS Research Test
29th Sep 20207:00 amRNSAppointment of Joint Broker
28th Sep 20209:00 amRNSPrice Monitoring Extension
28th Sep 20207:00 amRNSInterim Results for the Period Ended 30 June 2020
24th Sep 20207:00 amRNSUpdate on Integumen Collaboration
14th Sep 20207:00 amRNSNotice of Results and Investor Presentation
7th Sep 20207:00 amRNSAvacta to Launch SARS-CoV-2 ELISA Laboratory Test
2nd Sep 20207:00 amRNSExpansion of COVID-19 Test Manufacturing Capacity
20th Aug 20204:45 pmRNSIssue of Equity
19th Aug 20204:41 pmRNSSecond Price Monitoring Extn
19th Aug 20204:36 pmRNSPrice Monitoring Extension
19th Aug 20202:05 pmRNSSecond Price Monitoring Extn
19th Aug 20202:00 pmRNSPrice Monitoring Extension
18th Aug 20203:30 pmRNSIssue of Equity
18th Aug 20207:00 amRNSExpanded Partnership with LG Chem Life Sciences
17th Aug 20207:00 amRNSClarification Regarding Medusa 19 Antibody Test
11th Aug 20209:30 amRNSHolding(s) in Company
11th Aug 20207:00 amRNSTherapeutics Chief Development Officer Appointment
7th Aug 20207:00 amRNSSARS-CoV-2 Antigen Test Clinical Collaboration
6th Aug 20207:00 amRNSCOVID-19 Rapid Antigen Test Manufacturing Partner
29th Jul 20207:00 amRNSExpanded Partnership with Daewoong Pharmaceutical
22nd Jul 20207:00 amRNSUpdate on Adeptrix COVID-19 Diagnostic Test
17th Jul 20204:41 pmRNSSecond Price Monitoring Extn
17th Jul 20204:35 pmRNSPrice Monitoring Extension
13th Jul 20207:00 amRNSCollaboration with Integumen plc
7th Jul 20202:06 pmRNSIssue of Equity
3rd Jul 20204:41 pmRNSSecond Price Monitoring Extn
3rd Jul 20204:35 pmRNSPrice Monitoring Extension
24th Jun 202011:15 amRNSResult of General Meeting
24th Jun 20207:00 amRNSUpdate on COVID-19 Test Development Partnership
22nd Jun 20202:52 pmRNSResult of AGM
18th Jun 20207:00 amRNSUpdate on Affimer® Therapy for COVID-19 Infection
17th Jun 202011:05 amRNSSecond Price Monitoring Extn
17th Jun 202011:00 amRNSPrice Monitoring Extension
15th Jun 20204:41 pmRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.